Diffusion Pharmaceuticals Inc.

(DFFN) Trade

By |

Profile

Diffusion Pharmaceuticals Inc is a clinical stage biotechnology company. It is focused on extending the life expectancy of cancer patients by improving the effectiveness of current standard-of-care treatments, including radiation therapy and chemotherapy. Its lead product candidate is trans sodium crocetinate (TSC), which is used for the treatment of glioblastoma multiforme (GBM); Phase II pancreatic cancer; and metastatic brain cancer.

Contact Information

Website: www.diffusionpharma.com
Main Phone: +1 434 220-0718
Address: 1317 Carlton Avenue
Address 2: Suite 200
State: VA
City / Town: Charlottesville
Country: USA
Postal Code: 22902

Issuer Information

Exchange: NSC
CEO: David Kalergis
Employees: 11
Issuer Type: CS - Common Stock
Sector/Industry: Cyclical
NAICS: Biological Product (except Diagnostic) Manufacturing(325414)


Gathering Data... Please wait

Profile

Diffusion Pharmaceuticals Inc is a clinical stage biotechnology company. It is focused on extending the life expectancy of cancer patients by improving the effectiveness of current standard-of-care treatments, including radiation therapy and chemotherapy. Its lead product candidate is trans sodium crocetinate (TSC), which is used for the treatment of glioblastoma multiforme (GBM); Phase II pancreatic cancer; and metastatic brain cancer.

Contact Information

Website: www.diffusionpharma.com
Main Phone: +1 434 220-0718
Address: 1317 Carlton Avenue
Address 2: Suite 200
State: VA
City / Town: Charlottesville
Country: USA
Postal Code: 22902

Issuer Information

Exchange: NSC
CEO: David Kalergis
Employees: 11
Issuer Type: CS - Common Stock
Sector/Industry: Cyclical
NAICS: Biological Product (except Diagnostic) Manufacturing(325414)
$ 2.33 $ -0.01 (-0.43%)
Last Price 2.33 Change $ -0.01 Change % -0.43 Tick N/A
Bid 2.28 Bid Size 100.00 Ask 2.33 Ask Size 3,600.00
Open 2.30 High 2.34 Low 2.26 Prev Close 2.34
Last Trade Volume 30,949 52 Wk Hi 20.57 52 Wk Low 1.83
Market Cap 7.9 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 3,376,229.00 EPS (TTM) 17.55 PE Ratio 0.10 Exchange NCM
  Last 3 Mo Last 12 Mo
Number of Insider Trades 0 0
Number of Buys 0 0
Number of Sells 0 0
Net Activity 0 0
Last 10 Buys Shares
Mark Giles 1,000
Mark Giles 1,000
Last 10 Sell Shares
N/A 0
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 3 3 3 3
Low Target Price Estimate 1.25 1.25 1.25 1.25
Mean Target Price Estimate 2.13 2.13 2.13 2.13
Standard Deviation 1.24 1.24 1.24 1.24
Date of Most Recent Estimate 05/15/18 05/15/18 05/15/18 05/15/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 1 1 1 0
Moderate Buy 0 0 0 0
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1 1 1 0